76 related articles for article (PubMed ID: 1975943)
1. [Flow cytometric quantitation of the proliferation associated nuclear antigen p105 and DNA content of advanced gastric cancers as a prognostic factor: preliminary report].
Kimura H; Yonemura Y; Ohyama S; Kamata T; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):786. PubMed ID: 1975943
[No Abstract] [Full Text] [Related]
2. [Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in gastric cancer: preliminary report].
Kimura H; Yonemura Y; Ohyama S; Kamata T; Kosaka T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Feb; 91(2):293. PubMed ID: 1970113
[No Abstract] [Full Text] [Related]
3. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers.
Kimura H; Yonemura Y; Epstein AL
Cancer; 1991 Nov; 68(10):2175-80. PubMed ID: 1913456
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
6. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of p105 expression and malignancy in gastric cancers].
Yonemura Y; Oyama S; Kimura H; Kamata T; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Feb; 92(2):118-21. PubMed ID: 1674814
[TBL] [Abstract][Full Text] [Related]
9. [Correlation of proliferating cell nuclear antigen (PCNA) labeling rate and malignancy in gastric cancer: preliminary report].
Yonemura Y; Yamaguchi A; Kaji M; Fushida S; Tugawa K; Fonseca L; Miyazaki I
Nihon Geka Gakkai Zasshi; 1992 Jun; 93(6):661. PubMed ID: 1352850
[No Abstract] [Full Text] [Related]
10. [Expression of proliferation associated nuclear antigen P-105 in human gastric cancers: as a new marker for metastasis].
Oyama S; Yonemura Y; Tsugawa K; Kimura Y; Kamata T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):303-7. PubMed ID: 1675758
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity in gastric cancer determined with cell cycle-related monoclonal antibodies Ki-67 and p105: analysis by flow cytometry.
Kimura H; Yonemura Y; Miyazaki I
J Surg Oncol; 1992 Nov; 51(3):174-8. PubMed ID: 1359195
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.
Fitzgibbons PL; Turner RR; Appley AJ; Bishop PC; Nichols PW; Epstein AL; Apuzzo ML; Chandrasoma PT
Am J Clin Pathol; 1988 May; 89(5):640-4. PubMed ID: 2895977
[TBL] [Abstract][Full Text] [Related]
14. The proliferative fraction in lymph nodes: a comparison of proliferating cell nuclear antigen morphometry to flow cytometry.
Krauss JS; Pantazis CG; Chandler FW
Ann Clin Lab Sci; 1992; 22(3):189-96. PubMed ID: 1354428
[TBL] [Abstract][Full Text] [Related]
15. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms.
Teague K; el-Naggar A
Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288
[TBL] [Abstract][Full Text] [Related]
16. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms.
Steck K; el-Naggar AK
Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161
[TBL] [Abstract][Full Text] [Related]
17. Measurement of proliferative index in squamous cell carcinoma by flow cytometry.
Ferguson PJ; Garland A; Lampe HB
J Otolaryngol; 1992 Oct; 21(5):331-8. PubMed ID: 1361586
[TBL] [Abstract][Full Text] [Related]
18. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
Swanson SA; Brooks JJ
Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
[TBL] [Abstract][Full Text] [Related]
19. Smooth muscle tumors of the gastrointestinal tract. Flow cytometric quantitation of DNA and nuclear antigen content and correlation with histologic grade.
Kiyabu MT; Bishop PC; Parker JW; Turner RR; Fitzgibbons PL
Am J Surg Pathol; 1988 Dec; 12(12):954-60. PubMed ID: 3202248
[TBL] [Abstract][Full Text] [Related]
20. Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content.
Schutte B; Tinnemans MM; Pijpers GF; Lenders MH; Ramaekers FC
Cytometry; 1995 Oct; 21(2):177-86. PubMed ID: 8582238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
